✦ LIBER ✦

Corrigendum: Population pharmacokinetics of S(-)-carvedilol in healthy volunteers after administration of the immediate-release (IR) and the new controlled-release (CR) dosage forms of the racemate

✍ Scribed by Ahmed A. Othman; David M. Tenero; Duane A. Boyle; Natalie D. Eddington; Michael J. Fossler

Book ID: 118728904
Publisher: American Association of Pharmaceutical Scientists
Year: 2007
Tongue: English
Weight: 527 KB
Volume: 9
Category: Article
ISSN: 1550-7416
DOI: 10.1208/aapsj0903037c

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Population pharmacokinetics of S(−)-carv

Population pharmacokinetics of S(−)-carvedilol in healthy volunteers after administration of the immediate-release (IR) and the new controlled-release (CR) dosage forms of the racemate

✍ Ahmed A. Othman; David M. Tenero; Duane A. Boyle; Natalie D. Eddington; Michael 📂 Article 📅 2007 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 707 KB

The pharmacokinetics and pharmacodynamic

The pharmacokinetics and pharmacodynamics of metoprolol after conventional and controlled-release administration in combination with hydrochlorothiazide in healthy volunteers

✍ P. Lundborg; B. Abrahamsson; I. Wieselgren; M. Walter 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 302 KB

We have studied a controlled-release formulation containing metoprolol 100 mg and hydrochlorothiazide 12.5 mg. We compared the pharmacokinetics of both substances and the pharmacodynamics of metoprolol with those of a conventional combination tablet. The controlled-release formulation gave less vari

THE RELATIVE BIOAVAILABILITY OF TWO MARK

THE RELATIVE BIOAVAILABILITY OF TWO MARKETED CONTROLLED RELEASE DILTIAZEM DOSAGE FORMS AT STEADY STATE IN HEALTHY VOLUNTEERS

✍ C. L. Lippert; T. Arumugham; V. O. Bhargava; M. Eller; S. J. Weir 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 472 KB 👁 2 views

This study was conducted to determine the relative bioavailability of Dilacorm XR capsules compared to CardizemD CD capsules at both low (180mgdPL) and high (540mgd-') dose levels. Trough and serial plasma samples were obtained and pharmacokinetic parameters were calculated from the steady state con